Advocates and FDA try to blaze trail to regulatory compromise on CBD

Advocates and FDA try to blaze trail to regulatory compromise on CBD

At first-ever public hearing on CBD, advocates and FDA try to blaze trail to regulatory compromise

By NICHOLAS FLORKO

JEREMY REHM/AP

The meeting on Friday was the public kickoff of the FDA’s quest to sketch a clear framework to regulate CBD, or cannabidiol, products.

READ MORE